← Eichor
Study identifier: NCT06261554 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients

Condition: Food Allergy  ·  Sponsor: Medical University of Warsaw

PhaseNA
Planned participants39
Who can joinAll sexes, 3 Years to 17 Years
Healthy volunteersNo

About this study

It is a randomized, single-center, controlled trial to evaluate the effectiveness of oral immunotherapy with low-dose sesame protein compared with standard treatment (elimination diet) in patients with sesame allergy.

This description comes directly from the study's public registry record.

Talk to the study team

Katarzyna Grzela, PhD, MD  ·  +48 22 3179431  ·  katarzyna.grzela@wum.edu.pl

Joanna Zielińska, MD  ·  joanna_zielinska@outlook.com

Always discuss trial participation with your own doctor first.

Locations (1)

Medical University of WarsawWarsaw, Masovian Voivodeship, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06261554